ConductScience.org, home

Gene · 3913

NIH grants2,633

NIH grants whose papers are about the gene, through NIH's grant-paper links.

601 to 620 of 2,633

Download this page as JSON
GrantTitleLAMB2 papersNewest fiscal year
U54AR055073Rutgers University CounterACT Center of Excellence12024
UG3OD023272The Illinois Kids Development Study ECHO Pregnancy and Pediatric Cohort12024
UL1TR001453University of Massachusetts Center for Clinical and Translational Science12024
ZIADK043308Focal Segmental Glomerulosclerosis: Genetics & Mechanisms12024
ZIADK043411Focal segmental glomerulosclerosis: HIV-associated nephropathy12024
ZIADK043412Focal segmental glomerulosclerosis: Treatment12024
R01AG017917Epidemiologic Study of Neural Reserve and Neurobiology of Aging52023
U54DK083912Nephrotic Syndrome Rare Disease Clinical Research Network III42023
P20GM109095Center of Biomedical Research Excellence in Matrix Biology Phase II32023
R01EY015518Molecular mechanisms of anterior segment disorders32023
R01HL146574Endothelial laminin in blood brain barrier regulation32023
R01HL149407Regulation of the TGF-beta superfamily in the remodeling and failing heart32023
T32DK007695Research Training in Pediatric Nephrology32023
K12HD043483Building Interdisciplinary Research Careers in Women's Health22023
R01DK101528Cross talk between epithelial, inflammatory and mesenchymal cells in the development of portal fibrosis22023
R01GM132129Advancing Multiplexed Isobaric Tag-based Strategies for Proteome Profiling22023
T32GM007752Graduate Training in Cellular and Molecular Pharmacology22023
T32HL076122Multidisciplinary Training in Lung Biology22023
U24MH100928California NeuroAIDS Tissue Network22023
U24MH100929NATIONAL NEUROLOGICAL AIDS BANK22023

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3913/grants?page=31